MYCOBACTERIOLOGY INTRODUCTION RANGE OF LABORATORY SERVICES
|
|
- Dwain Garrett
- 5 years ago
- Views:
Transcription
1 MYCOBACTERIOLOGY INTRODUCTION The Central Tuberculosis Laboratory (CTBL) of the Department of Pathology provides laboratory diagnosis of tuberculosis (TB) and other mycobacterial diseases for all hospitals, clinics, laboratories and other healthcare facilities in Singapore. It has been the National Reference Laboratory for AFB* (Smear) Testing since 11 Feb In conjunction with the Licensing Unit of the Ministry of Health, Singapore, the Laboratory accreditates clinical laboratories performing AFB (acid-fast bacilli) smears in Singapore. RANGE OF LABORATORY SERVICES Services provided by the laboratory include: Acid-fast smear, Microscopic examination for acid-fast bacilli Culture for Mycobacterium species (AFB Culture) Direct detection for nucleic acid of M. tuberculosis complex * Identification of Mycobacterium tuberculosis complex Identification of M. bovis BCG Identification of non-tuberculous mycobacteria (NTM) Mycobacterial Viability Test Quantiferon Test Susceptibility testing for rapidly growing mycobacteria Susceptibility testing for M. avium complex (MAC) Susceptibility testing for M. kansasii Susceptibility testing for M. tuberculosis complex Susceptibility testing of M. tuberculosis complex for Pyrazinamide Strain Typing for TB * * This test is under validation at the time of publication. Contact laboratory (Tel: or to sng.li.hwei@sgh.com.sg) for further details. Please refer to respective test for special specimen collection and delivery instructions. Clinical specimens for all other mycobacterial investigations should be sent to or collected by: Client Services Section, Department of Pathology, Singapore General Hospital (Tel: , fax: ) _PathoH_SL.indd 197 4/3/08 1:03:06 PM
2 SECTION 4: SAMPLE COLLECTION & HANDLING SPECIAL INSTRUCTIONS & LAB TESTS SPECIAL INSTRUCTIONS ON SPECIMEN COLLECTION AND HANDLING Use the Request for Bacteriological Investigation form for SGH specimens and equivalent forms from other government, restructured and private hospitals, outpatient and private clinics and other organisations. Instructions for filling in the Request Form are given in the section Specimen Collection and Handling General Information. Indicate on the request form the type of the test to be performed. Please refer to the section Alphabetical Test Listing Mycobacteriology for the tests available. Verbal requests should be followed by laboratory request forms either faxed or sent to CTBL. For external clients, the forms should be sent through their respective laboratories to be referred to CTBL. Relevant clinical information including prior anti-mycobacterial treatment, previous smear, culture and susceptibility testing results should be included where possible. The attending doctor s name/mcr No. and contact number should be clearly indicated in the request form. Referring laboratories should include their 24-hour emergency number and contact person. COLLECTION AND TRANSPORTATION OF SPECIMENS 1. Collect specimen before starting patients on anti-mycobacterial drug therapy. 2. Collect specimens in sterile, screw-capped, leak-proof, disposable plastic containers with caps which should fit tightly and be of the type that cannot possibly become accidentally loose or cause leakage. Do not use waxed containers. 3. Label each container with the patient s name, NRIC number, nature of specimen, and date and time of collection. 4. Primary container/s for each specimen should be placed in a sealed biohazardlabelled plastic bag and accompanied by a request form with relevant patient and clinical data. Attach the request form to the outside of the plastic bag (Do not staple through the sealed portion of the bag). 5. Collect specimen aseptically, using standard precautions and minimising contamination with commensal organisms. These microbes will affect the smear and culture results. 6. Collect three first-morning sputum specimens for acid-fast smears and culture from patients with clinical and chest X-ray findings compatible with tuberculosis, on three separate days. 7. Avoid collecting specimens on swabs as these provide limited material for analysis. 8. Send specimens to the laboratory promptly, ideally within 30 minutes; at least within the day of collection. 9. Specimens should be refrigerated at 4 C within one hour of collection. Frozen specimens are unacceptable _PathoH_SL.indd 198 4/3/08 1:03:07 PM
3 MYCOBACTERIOLOGY 10. Mycobacterial cultures or suspected mycobacterial isolates for identification and susceptibility must be submitted on solid media. Primary containers should be screw-capped tightly and sealed properly with tape or parafilm before placing them into secondary containers (see point 4). Known M. tuberculosis complex isolates must be packed and transported according to MOH-BATA requirements. 11. For regional laboratories, contact CTBL before sending the specimen. The packaging must conform to international standards (IATA). SPECIMEN REQUIREMENTS FOR MYCOBACTERIAL ISOLATION AND ACID- FAST STAIN Specimen type Specimen requirement Special instructions Abscess contents, aspirated fluid Blood Body fluids (pleural, pericardial, peritoneal, etc) Bone Bone marrow Bronchoalveolar lavage or bronchial washing/brushing CSF As much as possible in sterile disposable container. 5 ml of plain blood inoculated directly into Myco-F-Lytic vial.* As much as possible (minimum ml) in sterile disposable container Bone in sterile disposable container with no fixative or preservative. Inoculate directly into Myco-F-Lytic vial* 5 ml in sterile disposable container 2 ml in sterile disposable container Disinfect skin with 70% alcohol before aspiration. Use swab to collect only if volume is insufficient for aspiration. Disinfect skin with 70% alcohol followed by iodine solution. Disinfect cap of Myco-F-Lytic vial with alcohol. Mix the contents immediately after collection. Mainly performed for immunocompromised patients, particularly those with AIDS. Please indicate such underlying condition on the form as prolonged culture incubation may be required. Disinfect skin with 70% alcohol if collecting by needle and syringe. Do not submit specimen in formalin. As for blood Avoid contaminating bronchoscope with tap water as free-living saprophytic mycobacteria may produce false-positive results. Disinfect skin before aspiration _PathoH_SL.indd 199 4/3/08 1:03:07 PM
4 SECTION 4: SAMPLE COLLECTION & HANDLING SPECIAL INSTRUCTIONS & LAB TESTS Specimen type Specimen requirement Special instructions Gastric lavage 5 10 ml in sterile disposable container. Collect in the morning soon after patient awakens in order to obtain sputum Collect fasting early morning specimen on three consecutive days. Use sterile saline. Collect in container containing sodium carbonate. swallowed during sleep. Laryngeal swabs Not recommended for the following reasons: Difficulty in proper collection Limited amount of material collected on swabs Risk of sharps injury from broken glass containers High rejection rate from unlabelled specimens Lymph node Skin lesion material Node or portion of node in sterile disposable container with no fixative or preservative. Send biopsy specimen or aspirate in sterile disposable container with no fixative or preservative. Collect aseptically. Select caseous portion if available. Do not freeze, immerse in formalin or other preservatives or wrap in gauze. For cutaneous ulcers, collect biopsy sample from periphery of lesion or aspirate material from under margin of lesion. Swabs in transport medium (Amies or Stuarts) are acceptable only if biopsy sample or aspirate is not obtainable. If infection was acquired in Africa, Australia, Mexico, South America, Indonesia, New Guinea or Malaysia, indicate this on request form, because Mycobacterium ulcerans may require prolonged incubation for primary isolation _PathoH_SL.indd 200 4/3/08 1:03:07 PM
5 MYCOBACTERIOLOGY Specimen type Specimen requirement Special instructions Sputum 5 10 ml in sterile, waxfree disposable container. Instruct patient to rinse mouth before sputum is collected. Collect an earlymorning specimen from deep productive cough on at least three consecutive days. Do not pool specimens (e.g. 24-hr pooled sputum); such samples and saliva are unacceptable. Induced sputum can be collected from patients who cannot or find it difficult to expectorate. For induced sputum, use sterile hypertonic saline. Avoid sputum contamination with nebuliser reservoir water. Indicate induced sputum on request form as these watery specimens resemble saliva. Stool Tissue biopsy sample Transtracheal aspirate 1 g in sterile disposable wax-free container 1 g of tissue, if possible, in sterile disposable container with no fixative or preservative As much as possible in a sterile disposable container Collect specimen directly into container or transfer from bedpan. Do not send frozen specimen. Recommended only for detection of Mycobacterium avium complex (MAC) involvement in the gastrointestinal tracts of patients with AIDS. Collect aseptically. Select caseous portion if available. Do not freeze, immerse in formalin or other preservatives or wrap in gauze _PathoH_SL.indd 201 4/3/08 1:03:17 PM
6 SECTION 4: SAMPLE COLLECTION & HANDLING SPECIAL INSTRUCTIONS & LAB TESTS Specimen type Specimen requirement Special instructions Urine Collect at least 40 ml of mid-stream clean catch or catheterised urine in sterile disposable container. Collect as much as possible of suprapubic urine in a sterile disposable container. Collect first morning specimen on three consecutive days. 24-hour pooled specimens or urine from catheter bag are unacceptable. Specimens of < 40 ml are unacceptable unless a larger volume is not obtainable. The first morning void provides the best yield. Specimens collected at other times are diluted and not optimal. Wound material See biopsy or aspirate Due to limited material collected, swabs are acceptable only if biopsy or aspirate is not obtainable. If used, send the swab in transport medium (Amies or Stuarts). Available upon request from Client Services* _PathoH_SL.indd 202 4/3/08 1:03:18 PM
7 MYCOBACTERIOLOGY ALPHABETICAL TEST LISTING MYCOBACTERIOLOGY ACID-FAST SMEAR, MICROSCOPIC EXAMINATION OF AFB Type of test : Routine Sample required : Sputum, bronchoalveolar lavage, CSF, body fluid, tissue, pus etc : Smear prepared from digested, decontaminated and concentrated sample Screening: Auramine O stain Fluorescent microscopy Confirmatory: Ziehl Nielsen stain : Acid-fast bacilli seen (with quantitation) / No acid-fast bacilli seen Quantitation according to United States Centers for Disease Control and Prevention (CDC method): Number of AFB seen Report Fuchsin stain (1000x) Fluorochrome stain (450x) 0 0 No AFB seen 1-2/300F 1-2/70 F Doubtful* 1-9/100F 2-18/50F /10F 4-36/10F /F 4-36/F 3 + > 9/F > 36/F 4 + * Not considered positive. Smears are repeated from either the same or a second specimen. Turnaround time Day(s) test set up : 8 24 hours : Monday Saturday AFB CULTURE, MYCOBACTERIAL CULTURE (CLINICAL SPECIMENS) Test type : Routine Specimen required : Sputum, bronchoalveolar lavage, CSF, body fluids, gastric lavage, tissue, urine, pus, etc : Culture by MGIT non-radiometric method and LJ solid media. Alternate media include BACTEC 460 Radiometric or 7H10 solid media. Includes reflex drug testing : First-line susceptibility testing for M. tuberculosis (MGIT) for the first MTBC isolate cultured for new TB cases and upon follow-up at 6 8 weeks. Second-line panel automatically performed for isolates resistant to isonizid, rifampin or ethambutol _PathoH_SL.indd 203 4/3/08 1:03:18 PM
8 SECTION 4: SAMPLE COLLECTION & HANDLING SPECIAL INSTRUCTIONS & LAB TESTS Special request and separate charges apply for the following: M. tuberculosis Isolates that do not meet the above criteria for reflex testing Pyrazinamide susceptibility testing of M. tuberculosis (MGIT method) Extended-line susceptibility testing for M. tuberculosis e.g. Capreomycin, clofazamine and PAS, (BACTEC 460 method) Identification of NTM isolated from sputa that do not meet ATS criteria for significance : (a) M. tuberculosis complex** isolated. Susceptibility test result pending / refer to previous cultures for susceptibility test results (b) Nontuberculous mycobacteria isolated (c) AFB culture overgrown with non-mycobacterial organism/s (d) No growth of AFB Turnaround time Day(s) test set up ** M. tuberculosis complex includes M. tuberculosis, M. bovis, M. bovis BCG, M. africanum, M. canettii and M. microti. : (a) Receipt of specimen to detection of growth (average: 21 days). Affected by type of organism, specimen received and prior antibiotic treatment (b) Detection of growth to final identification (range of 2 days to 4 weeks, average 5 7 days for MTBC) Affected by slow growing mycobacteria, mixed cultures requiring additional processing and repeat cultures Negatives: 6 8 weeks : Monday Saturday DIRECT DETECTION FOR NUCLEIC ACID OF M. TUBERCULOSIS COMPLEX Type of test : Routine Specimen required : As for Mycobacterial Culture except that blood and bone marrow specimens should be collected in sterile screwcapped containers or plain Vacutainer tubes (NOT in Myco-F-Lytic vials) and delivered to the lab immediately. If delay is unavoidable, collect in EDTA or citrated tubes, though amplification results may be less consistent. Special instructions : Collect in a dedicated container. Do not order non- CTBL tests using the same request form and on the same specimen. Specimens should reach CTBL within 24 hours of collection. If transport delay is unavoidable, store at 4 C. Reflex testing : This test only provides preliminary information for empirical TB management. A reflex AFB smear and culture (both chargeable) is set up on each specimen. Written instruction from the doctor is necessary if these are not to be performed _PathoH_SL.indd 204 4/3/08 1:03:18 PM
9 MYCOBACTERIOLOGY Turnaround time Day(s) test set up : ProbeTec Assay (BD ProbeTec ET system) using strand displacement amplification (SDA). The alternate method used is the Amplification Mycobacterium tuberculosis Direct test (AMTD) based on transcription-mediated amplification. : M. tuberculosis complex DNA detected / Not detected (BD ProbeTec) M. tuberculosis complex rrna detected / Not detected (AMTD) : 2 5 days : Once a week IDENTIFICATION OF MYCOBACTERIA Specimen required : Referred isolate from other laboratories. Please contact CTBL at telephone before sending isolate. Fresh pure culture of isolate on slant in sealed, screwcapped plastic tube. Tube should be tightly closed, labelled with identifying lab number and placed in a biohazardlabelled ziplock bag. Pack and transport according to MOH-BATA requirements. Request form (stating name and address of referring laboratory, source of mycobacterial isolate, patient particulars with relevant clinical information, clinician in-charge and requester s contact number) is to be placed in separate sealed plastic bag outside the ziplock bag. The type of test should be specified as Mycobacterial Identification. For regional labs, packaging must conform to IATA standards. : AFB smear, culture, DNA probes, HPLC, sequencing and biochemical tests : Species identified reported Turnaround time : 4 weeks depending on the nature of the organism Day(s) test set up : Monday Saturday IDENTIFICATION OF M. BOVIS BCG AND NTM Specimen required : For mycobacteria isolated in CTBL or in other laboratories Referred M. tuberculosis complex isolates for identification of BCG from other laboratories please contact CTBL before sending isolate. Fresh pure culture isolate on slant in sealed screw-capped plastic tube. Tube should be tightly closed, labelled with identifying lab number and placed in a biohazard-labelled ziplock bag. Pack, transport and notify CTBL (in advance) and MOH of the transfer, according to MOH-BATA requirements for M. tuberculosis complex. Referred NTM for identification: Fresh pure culture isolate on slant in sealed screw-capped plastic tube. Tube should be tightly closed, labelled with identifying lab number and placed in a biohazard-labelled ziplock bag _PathoH_SL.indd 205 4/3/08 1:03:18 PM
10 SECTION 4: SAMPLE COLLECTION & HANDLING SPECIAL INSTRUCTIONS & LAB TESTS Test report Turnaround time Day(s) test set up MYCOBACTERIAL VIABILITY Specimen required Turnaround time Day(s) test set up QUANTIFERON TEST Specimen required Special instructions Turnaround time Day(s) test set up Regional laboratories must make arrangements with the lab for the MOH-Import Permit before sending specimens and packaging must conform to international standards (IATA). The Request form should state the name and address of referring laboratory, organism identification, clinical source, patient particulars with relevant clinical information, clinician in-charge and requester s contact number. The type of test request should be specified as Identification of BCG or NTM. Forms are to be placed in a separate sealed plastic bag in the outer package. : HPLC, probes, molecular : Mycobacteria species identified : 1 week to 2 months, depending on species : Monday Friday : Post-inactivation samples : MGIT broth culture : Positive, Negative for AFB : 6 weeks for Negatives. 2 6 weeks for Positives : Upon request : Whole blood collected into Quantiferon Nil, TBAg and Mitogen tubes. 1 ml in each Nil (grey), TBAg (red) and mitogen (purple) Quantiferon tube. Acceptable range per tube = ml : Quantiferon tubes are available from either SGH SOC Lab at Block 3 or CTBL and should be stored at 4 C till specimen collection. Do not collect on Saturdays and the eve of public holidays. Visually check that the blood level is approximately at the 1 ml marking on each tube before withdrawing the phlebotomy needle. Recollect in a fresh tube if there is over or underfilling. Shake the tubes 10 times after collection and transport upright at room temperature to SGH SOC Lab level 1 before 4 pm on the same day or hand-deliver directly to CTBL. : QuantiFERON TB-Gold In-tube. IFN-γ level detected by EIA : Positive, Negative, Indeterminate : Negatives: 2 5 days Positives and Indeterminates 4 7 days : 3 times a week _PathoH_SL.indd 206 4/3/08 1:03:19 PM
11 MYCOBACTERIOLOGY SUSCEPTIBILITY TESTING FOR MAC Specimen required : M. avium complex isolated and identified at CTBL. Isolates identified in referring labs must specify the organism identification and clinical source on the lab request form. For further instructions, refer under Mycobacterial Identification. Indication : Should be performed on isolates from blood or tissue (disseminated disease) and clinically significant respiratory specimens from patients who have failed prior macrolide therapy or prophylaxis Drug tested : Clarithromycin. For alternative drugs, please contact CTBL. : Radiometric. Minimum Inhibitory Concentration breakpoint testing : Susceptible, Resistant Turnaround time : 2 weeks Day(s) test set up : Monday Friday SUSCEPTIBILITY TESTING FOR M. KANSASII Specimen required : M. kansasii isolated and identified at CTBL. Isolates identified in referring labs must specify the organism identification and clinical source on the lab request form. For further instructions, refer under Mycobacterial Identification. Drug Tested : Rifampicin : Radiometric. Minimum Inhibitory Concentration breakpoint testing : Susceptible, Resistant Turnaround time : 2 weeks Day(s) test set up : Monday Friday SUSCEPTIBILITY TESTING FOR RAPIDLY GROWING MYCOBACTERIA Specimen required : Rapidly growing mycobacteria (RGM) isolated and identified at CTBL. Isolates identified in referring labs must specify the organism identification and clinical source on the lab request form. For further instructions, refer under Mycobacterial Identification. : Microbroth dilution method Drugs tested : Amikacin, cefoxitin, ciprofloxacin, clarithromycin, doxycycline, ertapenem, imipenem (not reported for M. abscessus chelonae complex), linezolid, levofloxacin, moxifloxacin, tigecycline, tobramycin (M. abscessus from eye cultures only) and sulfamethoxazole : Susceptible, Intermediate, Resistant according to NCCLS interpretive criteria Turnaround time : 1 2 weeks Days(s) Test set up : Once a week _PathoH_SL.indd 207 4/3/08 1:03:19 PM
12 SECTION 4: SAMPLE COLLECTION & HANDLING SPECIAL INSTRUCTIONS & LAB TESTS SUSCEPTIBILITY TESTING OF M. TUBERCULOSIS COMPLEX Specimen required : Referred M. tuberculosis complex isolates from other laboratories. Please contact CTBL before sending isolate. Fresh pure culture of M. tuberculosis isolate on slant in sealed screw-capped plastic tube. Tube should be tightly closed, labelled with identifying lab number and placed in a biohazard-labelled ziplock bag. Pack, transport and notify CTBL (in advance) and MOH of the transfer, according to MOH-BATA requirements. Regional laboratories must make arrangements with the lab for the MOH-Import Permit before sending specimens and packaging must conform to international standards (IATA). The request form should state the name and address of referring laboratory, organism identification, clinical source, patient particulars with relevant clinical information, clinician in-charge and requester s contact number. The type of test request should be specified as TB Culture for Susceptibility Testing. Forms are to be placed in a separate sealed plastic bag in the outer package. : MGIT non-radiometric for first line and BACTEC460 radiometric for second and third. Minimum Inhibitory Concentration breakpoint testing First line drugs: Streptomycin, Rifampicin, Isoniazid, Ethambutol Second line drugs: Ofloxacin, kanamycin, ethionamide Extended panel: Capreomycin, clofazamine and PAS : Susceptible, Resistant Turnaround time : 2 weeks. Affected by slow-growing isolates Day(s) test set up : Monday Saturday SUSCEPTIBILITY TESTING OF M. TUBERCULOSIS COMPLEX FOR PYRAZINAMIDE Specimen required : M. tuberculosis complex isolates from clinical specimens cultured at Central TB Laboratory. Test must be specified on lab request form. : MGIT. Minimum Inhibitory Concentration breakpoint testing : Susceptible, Borderline resistant, Resistant Turnaround time : 2 weeks Day(s) test set up : Monday Saturday _PathoH_SL.indd 208 4/3/08 1:03:19 PM
MYCOBACTERIOLOGY SERVICE MANUAL
MYCOBACTERIOLOGY SERVICE MANUAL The Office of Laboratory Services (OLS) provides primary isolation and identification of Mycobacterium species in human diagnostic specimens. Reference specimens of AFB
More informationOverview of Mycobacterial Culture, Identification, and Drug Susceptibility Testing
Overview of Mycobacterial Culture, Identification, and Drug Susceptibility Testing 1. Essentials for the Mycobacteriology Laboratory: Promoting Quality Practices 1.1 Overview: Mycobacterial Culture, Identification,
More informationAPPENDIX E COLLECTION AND SUBMISSION OF SPECIMENS FOR TB TESTING
APPENDIX E COLLECTION AND SUBMISSION OF SPECIMENS FOR TB TESTING For additional information about the collection, transport or submission of specimens for AFB examination, contact BC Public Health & Microbiology
More informationTB Laboratory for Nurses
TB Laboratory for Nurses Shea Rabley, RN, MN Consultant Mayo Clinic Center for Tuberculosis 2014 MFMER slide-1 Disclosures None 2014 MFMER slide-2 Objectives Participants will be able to: 1. Name 2 safety
More informationPublic Health Mycobacteriology (TB) Laboratory Testing Services
Public Health Mycobacteriology (TB) Laboratory Testing Services Gary Budnick Supervising Microbiologist Connecticut Department of Public Health Laboratory Branch Hartford, Connecticut Specimen Collection
More informationProvidence Medford Medical Center Pathology Department
Providence Medford Medical Center Pathology Department Anatomic pathology services including histology, cytology and autopsies are offered through Providence Medford Medical Center Pathology Department.
More informationWSLH Testing and Surveillance Updates
WSLH Testing and Surveillance Updates Wisconsin Mycobacteriology Laboratory Network annual conference November 4, 2015, Madison, WI Updates Outline Collection and Transport Smear and Culture Nucleic Acid
More informationThe ABC s of AFB s Laboratory Testing for Tuberculosis. Gary Budnick Connecticut Department of Public Health Mycobacteriology Laboratory
The ABC s of AFB s Laboratory Testing for Tuberculosis Gary Budnick Connecticut Department of Public Health Mycobacteriology Laboratory Laboratory TAT Goals Case Study Specimen Collection Testing Contact
More informationFrances Morgan, PhD October 21, Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS
The Laboratory s Role in Caring for Patients Diagnosed with TB Frances Morgan, PhD October 21, 2015 Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS EXCELLENCE
More informationMicroscopic Morphology in Smears Prepared from MGIT Broth Medium for Rapid Presumptive Identification of Mycobacterium tuberculosis
Annals of Clinical & Laboratory Science, vol. 33, no. 2, 2003 179 Microscopic Morphology in Smears Prepared from MGIT Broth Medium for Rapid Presumptive Identification of Mycobacterium tuberculosis complex,
More informationCollection and Transportation of Clinical Specimens
Collection and Transportation of Clinical Specimens IDK II Faculty of Nursing Universitas Indonesia PDF Created with deskpdf PDF Writer - Trial :: http://www.docudesk.com The laboratory diagnosis of an
More informationMycobacterial cell wall. Cell Cycle Lengths. Outline of Laboratory Methods. Laboratory Methods
Laboratory Methods Cell Cycle Lengths Generation time (hrs) Days needed for 26 generations (colony) E. coli 0.33 0.36 Nancy Connell, PhD Professor, nfectious Disease Department of Medicine Center for Emerging
More informationTB/HIV 2 sides of the same coin. Dr. Shamma Shetye, MD Microbiology Metropolis Healthcare, Mumbai
TB/HIV 2 sides of the same coin Dr. Shamma Shetye, MD Microbiology Metropolis Healthcare, Mumbai Global- Tb new cases Diagnosis-Microscopy ZN,Flourescent microscopy(fm) Rapid, inexpensive test Specificity>95%
More informationWELCOME. Lab Talk: What a Nurse Hears. April 18, NTNC Annual Meeting Lab Talk: What a Nurse Hears
Lab Talk: What a Lab Talk: What a Max Salfinger, MD, FIDSA, FAAM Executive Director, Advanced Diagnostic Laboratories Laboratory Director, Mycobacteriology & Pharmacokinetics National Jewish Health Lisa
More informationKen Jost, BA, has the following disclosures to make:
Diagnosis of TB Disease: Laboratory Ken Jost, BA May 10, 2017 TB Intensive May 9-12, 2017 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Ken Jost, BA, has the following disclosures to make: No conflict
More informationReceipt within 1 day of specimen collection. Report AFB b smear result within 1 day from receipt of specimen
Recommendation Promote rapid delivery of specimens to the laboratory Use fluorescent acid-fast staining and promptly transmit results by phone, FAX, or electronically Identify growth as acid-fast and use
More informationTB 101 Disease, Clinical Assessment and Lab Testing
TB 101 Disease, Clinical Assessment and Lab Testing Pacific Islands Tuberculosis Controllers Association Conference (PITCA) Clinical Laboratory Breakout None Disclosure Objectives Be able to list and explain
More informationXpert MTB/RIF Training. Indira Soundiram 2012
Xpert MTB/RIF Training Indira Soundiram 2012 A Better Way to Platform Design GeneXpert Infinity-48 GeneXpert Module GX-I GX-II GX-IV GX-XVI 2 Defining Molecular Diagnostics Any Test Any Time Any Sample
More informationStacy White, PhD May 12, TB for Community Providers. Phoenix, Arizona
Role of the Laboratory in TB Diagnosis Stacy White, PhD May 12, 2015 TB for Community Providers May 12, 2015 Phoenix, Arizona EXCELLENCE EXPERTISE INNOVATION Stacy White, PhD has the following disclosures
More informationIrish Mycobacteria Reference Laboratory St James s Hospital
Edition No. 09 IMRL Doc. No.: LP-IMRL-0042 Author:: Margaret Fitzgibbon Date: 20.02.17 Authorised By: Emma Roycroft Issue Date: 24.02.17 St James s Hospital User Manual IMRL User Manual Page 1 of 28 THE
More informationHANDLING GENERAL INFORMATION TEST REQUESTS TYPES OF TESTS TEST REQUEST FORM
SECTION 3: SAMPLE COLLECTION & HANDLING GENERAL INFORMATION SAMPLE INTRODUCTION COLLECTION & HANDLING GENERAL results. INFORMATION The quality of laboratory test results depends greatly on the quality
More informationMicrobiology Collection
Microbiology Collection Notify the Microbiology Laboratory at 920-738-6317 if any of the following etiological agents are suspected to be present in the specimens sent to the laboratory. Bacillius anthracis
More informationObjectives. TB Laboratory Methods
TB Laboratory Methods Beverly Metchock, Dr.P.H., D(ABMM) Team Leader, Reference Laboratory, Mycobacteriology Laboratory Branch February 2011 Objectives General overview of mycobacteriology (TB) lab practices
More informationTB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?
Those oral antibiotics are just not working! Inpatient Standards of Care & Discharge Planning S/He s in the Hospital: Now What Do I Do? Dana G. Kissner, MD TB Intensive Workshop, Lansing, MI 2012 Objectives:
More informationDiagnosis of TB: Laboratory Ken Jost Tuesday April 1, 2014
TB Nurse Case Management San Antonio, Texas April 1 3, 2014 Diagnosis of TB: Laboratory Ken Jost Tuesday April 1, 2014 Ken Jost, BA has the following disclosures to make: No conflict of interests No relevant
More informationTB Intensive San Antonio, Texas November 11 14, 2014
TB Intensive San Antonio, Texas November 11 14, 2014 Diagnosis of TB: Laboratory Ken Jost, BA November 12, 2014 Ken Jost, BA has the following disclosures to make: No conflict of interests No relevant
More informationSHASTA PATHOLOGY ASSOCIATES CYTOLOGY SPECIMEN COLLECTION
SHASTA PATHOLOGY ASSOCIATES CYTOLOGY SPECIMEN COLLECTION I. PRINCIPLE: Proper collection and handling of all cytology specimens helps ensure the most accurate results possible from the specimen. Cytology
More informationChapter 4 Diagnosis of Tuberculosis Disease
Chapter 4 Diagnosis of Tuberculosis Disease Table of Contents Chapter Objectives.... 75 Introduction.... 77 Medical Evaluation.......................................................... 78 Chapter Summary...
More informationCDPH - CTCA Joint Guidelines Guideline for Micobacteriology Services In California
CDPH - CTCA Joint Guidelines Guideline for Micobacteriology Services In California These guidelines are intended to be used as an educational aid to help clinicians make informed decisions about patient
More information<<Insert Laboratory Logo if applicable>> LABORATORY MANUAL MYCOBACTERIOLOGY CLINICAL SITE
LABORATORY MANUAL MYCOBACTERIOLOGY CLINICAL SITE Protocol Title: A Phase 3, Open-Label Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability
More informationCHAPTER 3: DEFINITION OF TERMS
CHAPTER 3: DEFINITION OF TERMS NOTE: TB bacteria is used in place of Mycobacterium tuberculosis and Mycobacterium tuberculosis complex in most of the definitions presented here. 3.1 Acid-fast bacteria
More informationTB Nurse Case Management. March 7-9, Diagnosis of TB: Ken Jost Wednesday March 7, 2012
TB Nurse Case Management San Antonio, Texas March 7-9, 2012 Diagnosis of TB: Laboratory Ken Jost Wednesday March 7, 2012 Ken Jost has the following disclosures to make: No conflict of interests No relevant
More informationLaboratory Diagnostic Techniques. Hugo Donaldson Consultant Microbiologist Imperial College Healthcare NHS Trust
Laboratory Diagnostic Techniques Hugo Donaldson Consultant Microbiologist Imperial College Healthcare NHS Trust Learning Objectives 1) When to consider a diagnosis of TB 2) When to consider a referral
More informationSECTION 13.0 SPECIMENS FOR LABORATORY EXAMINATION
SECTION 13.0 SPECIMENS FOR LABORATORY EXAMINATION Introduction Collection of Specimens for Microbiological Examination: Safe Handling of Specimens Packaging & Transportation of Specimens Specimen Rejection
More informationMICROBIOLOGY SPECIMEN COLLECTION MANUAL
Lee Memorial Health System Lee County, FL CLINICAL LABORATORY MICROBIOLOGY SPECIMEN COLLECTION MANUAL ACID FAST CULTURE Specimen Type see Specimen Chart ACID FAST STAIN see Specimen Chart Acid Fast stain
More informationRole of the Laboratory in TB Diagnosis and Management
Role of the Laboratory in TB Diagnosis and Management Michael Pentella, Ph.D., D(ABMM), CIC Associate Director University Hygienic Lab Clinical Associate Professor, College of Public Health, University
More informationHISTOPATHOLOGY DEPARTMENT
HISTOPATHOLOGY DEPARTMENT TITLE: Cytology and andrology user guide INDEX ORGANISATIONAL UNIT AREA OF APPLICATION DOCUMENT TYPE AUTHOR(S) AUTHORISED BY AUTHORISATION DATE DATE PRINTED COPY NUMBER LOCATION
More informationEffective Date: SPECIMEN COLLECTION FOR CULTURE OF BACTERIAL PATHOGENS QUICK REFERENCE
1 of 9 Policy #: Subject: 611 (PLH-611-06) Effective Date: 9/30/2004 Reviewed Date: 8/1/2016 SPECIMEN COLLECTION FOR CULTURE OF BACTERIAL PATHOGENS QUICK REFERENCE Approved by: Laboratory Director, Jerry
More informationMycobacteria & Tuberculosis PROF.HANAN HABIB & PROF ALI SOMILY DEPRTMENT OF PATHOLOGY, MICROBIOLOGY UNIT COLLEGE OF MEDICINE
Mycobacteria & Tuberculosis PROF.HANAN HABIB & PROF ALI SOMILY DEPRTMENT OF PATHOLOGY, MICROBIOLOGY UNIT COLLEGE OF MEDICINE Objectives l Recognize that tuberculosis as a chronic disease mainly affecting
More informationDiagnosis of TB: Laboratory Ken Jost Tuesday April 9, 2013
TB Nurse Case Management San Antonio, Texas April 9-11, 2013 Diagnosis of TB: Laboratory Ken Jost Tuesday April 9, 2013 Ken Jost has the following disclosures to make: No conflict of interests No relevant
More informationTargeted Testing and the Diagnosis of. Latent Tuberculosis. Infection and Tuberculosis Disease
Self-Study Study Modules on Tuberculosis Targeted Testing and the Diagnosis of Latent Tuberculosis Infection and Tuberculosis Disease 1 Module 3: Objectives At completion of this module, learners will
More informationAFB Identification Texas Approach
AFB Identification Texas Approach Ken Jost Texas Department of State Health Services 6th National Conference on Laboratory Aspects of TB June 21, 2010 DSHS-Austin TB Lab Customers & Samples Year 2009 175
More information5. Use of antibiotics, which disturbs balance of normal flora. 6. Poor nutritional status.
Microbiology Chapter 5 Introduction to Pathogens 5:1 Changing Patterns of Disease In the past 100 years, since the discovery of the Germ Theory of Disease was accepted: We have learned that microbes cause
More informationPathology Specimen Handling Requirements
CONWAY REGIONAL HEALTH SYSTEM CLINICAL LABORATORY Pathology Specimen Handling Requirements POLICY: Tissue or body fluids, etc. removed or collected during any procedure for purposes of Pathologist examination
More informationMycobacteria Diagnostic Testing in Manitoba. Dr. Michelle Alfa Medical Director, DSM Clin Micro Discipline
Mycobacteria Diagnostic Testing in Manitoba Dr. Michelle Alfa Medical Director, DSM Clin Micro Discipline Acknowlegements: Assunta Rendina: Charge Tech HSC Lab Joyce Wolf & Dr. Meenu Sharma: NML Dr. Kanchana
More informationFrances Jamieson, MD and Kevin May, BSc November 15 th,
Frances Jamieson, MD and Kevin May, BSc November 15 th, 2016 1 TB Elimination: Back To Basics Financial Interest Disclosure (over the past 24 months) Dr. Frances amieson Company Speaker Advisory Research
More informationGuidelines for Tuberculosis Control in New Zealand 2010 Chapter 11: Mycobacteriology: Laboratory Methods and Standards
Guidelines for Tuberculosis Control in New Zealand 2010 Chapter 11: Mycobacteriology: Laboratory Methods and Standards Ministry of Health. 2010. Guidelines for Tuberculosis Control in New Zealand 2010.
More informationTISSUE COLLECTION. SCPA 603- Histopathological Techniques for Routine and Research
TISSUE COLLECTION SCPA 603- Histopathological Techniques for Routine and Research Somphong Narkpinit, MD. Department of Pathobiology Faculty of Science, Mahidol University somphong.nar@mahidol.ac.th Learning
More informationCase Study 2016 Wisconsin Mycobacteriology Laboratory Network Annual Conference November 17, 2016
Case Study 2016 Wisconsin Mycobacteriology Laboratory Network Annual Conference November 17, 2016 Raymond P. Podzorski, Ph.D, D(ABMM) St. Mary s Hospital Laboratory and Wisconsin Region SSMHealth 608-258-6393
More informationClostridium difficile Specimen Collection
Clostridium difficile Specimen Collection Collect stool specimens into a clean, airtight container with no preservative. All stool specimens should be tested as soon as possible. Ideally, stool specimens
More informationTechnical Bulletin No. 172
CPAL Central Pennsylvania Alliance Laboratory QuantiFERON -TB Gold Plus Assay Contact: J Matthew Groeller, MPA(HCM), MT(ASCP), 717-851-4516 Operations Manager, Clinical Pathology, CPAL Jennifer Thebo,
More informationLaboratory Diagnosis and Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis Complex. Objectives
Laboratory Diagnosis and Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis Complex Marie-Claire Rowlinson, PhD D(ABMM) Calin Chiribau, PhD, MT(ASCP) Florida Bureau of Public Health Laboratories
More informationIdentify, Evaluate, and Treat! Steps to Improve TB Contact Investigation in the Pacific November 27 30, 2018
TB Laboratory Training Chuuk, FedSM Vasiti Uluiviti Regional Lab Strengthening Coordinator PIHOA November 29 th 218 1 Learning objectives Provide an overview of TB lab activities in the USAPI Demonstration
More informationMIC = Many Inherent Challenges Sensititre MIC for Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis complex
MIC = Many Inherent Challenges Sensititre MIC for Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis complex Marie Claire Rowlinson, PhD D(ABMM) Florida Bureau of Public Health Laboratories
More informationCollection (Specimen Source Required on all tests) Sputum: >5 ml required. First morning specimen preferred.
Type Acid Fast (Mycobacteria) Sputum: >5 ml required. First morning specimen preferred. For blood, sodium heparin tube preferred. Lithium heparin acceptable. Do not centrifuge.. delay. Swabs are not appropriate
More informationLatent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016
Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016 Randy Culpepper, MD, MPH Deputy Heath Officer/Medical Director Frederick County Health Department March 16, 2016 2 No
More informationSpecimen Submission Guide
Specimen Submission Guide 5802 Wright Drive Loveland, CO 80538 Phone (970) 212-0530 Fax (970) 212-0553 Toll Free (800) 920-6227 1 Table of Contents Gynecologic Cytology and Affiliated Molecular Testing
More informationCommunicable Disease Control Manual Chapter 4: Tuberculosis
Provincial TB Services 655 West 12th Avenue Vancouver, BC V5Z 4R4 www.bccdc.ca Communicable Disease Control Manual Definitions Page 1 2.0 DEFINITIONS Many of the definitions that follow are taken from
More informationThe diagnostic value of gyrb RFLP PCR. Mycobacteria in patients with clinical. in Mazandaran
Mazandaran University of Medical Sciences The diagnostic value of gyrb RFLP PCR test t in differentiation between pathogenic Mycobacteria in patients with clinical suspicions spicions of tuberculosis in
More informationMycobacterium tuberculosis: Assessing Your Laboratory
Mycobacterium tuberculosis: Assessing Your Laboratory APHL Tool 2013 EDITION The following individuals contributed to the preparation of this edition of Mycobacterium tuberculosis: Assessing Your Laboratory
More informationStandardized Case Definition for Extrapulmonary Nontuberculous Mycobacteria Infections
Operational Guidance for Position Statement 17 ID 07: Standardized Case Definition for Extrapulmonary Nontuberculous Mycobacteria Infections Submission Date: April 28, 2017 Committee: Infectious Disease
More informationTB Nurse Case Management Davenport, Iowa September 27 28, 2011
TB Nurse Case Management Davenport, Iowa September 27 28, 2011 Role of the Laboratory in the TB Diagnosis and Management Michael Pentella, PhD, MS, SM(ASCP), CIC, D(ABMM) September 27, 2011 Michael Pentella,
More informationMonitoring the Health of Transplanted Organs DONOR GENOTYPING MANUAL
Monitoring the Health of Transplanted Organs DONOR GENOTYPING MANUAL 10101 Innovation Drive. Suite 600. Wauwatosa, WI 53226 1-888-214-3151 MKT-008 v3.0 MKT-008 v3.0 TABLE OF CONTENTS I Intended Use...
More informationTest Requested Specimen Ordering Recommendations
Microbiology Essentials Culture and Sensitivity (C&S) Urine C&S Catheter Surgical (excluding kidney aspirates) Voided Requisition requirements o Specific method of collection MUST be indicated o Indicate
More informationShannon Kasperbauer, M.D. National Jewish Health University of Colorado Health Sciences Center. Property of Presenter. Not for Reproduction
Shannon Kasperbauer, M.D. National Jewish Health University of Colorado Health Sciences Center Consultant: Johnson and Johnson Speaker/consultant: Insmed Examine characteristics of the RGM Define the main
More informationAppendix C. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997)
Appendix C Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Since publication of the Recommendations for Counting Reported Tuberculosis Cases 1 in January 1977, numerous changes
More informationSAMPLE. Collecting a faeces specimen
7. Perform steps 10 16 of the common steps (see pp. 39 43). Evidence base: PHE (2014a) To ensure that: the patient is safe and comfortable. the specimen has been correctly collected and documented in the
More informationSpecimen Submission Guide
Specimen Submission Guide 5802 Wright Drive Loveland, CO 80538 Phone (970) 212-0530 Fax (970) 212-0553 Toll Free (800) 920-6227 1 Table of Contents Gynecologic Cytology and Affiliated Molecular Testing
More informationSpecimen Collection and Source Mapping
Specimen Collection and Source Mapping October 4, 2016 Steve Renfroe MT(ASCP) Consultant, Clinical Specialty What is Your Culture? Does your urinalysis reflex to culture? Does Lab educate your Nursing
More informationAppendix B. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997)
Appendix B Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Since publication of the Recommendations for Counting Reported Tuberculosis Cases 1 in January 1977, numerous changes
More informationClarithromycin-resistant Mycobacterium Shinjukuense Lung Disease: Case Report and Literature Review
Showa Univ J Med Sci 28 4, 373 377, December 2016 Case Report Clarithromycin-resistant Mycobacterium Shinjukuense Lung Disease: Case Report and Literature Review Makoto HAYASHI 1, Satoshi MATSUKURA 1,
More informationJOB A IDS for collection, storage and transport of specimens for laboratory confirmation of Middle East respiratory syndrome coronavirus (MERS-CoV)
JOB A IDS for collection, storage and transport of specimens for laboratory confirmation of Middle East respiratory syndrome coronavirus (MERS-CoV) Integrated Disease Surveillance Programme Disease Prevention
More informationNon-Gynecologic Cytology Specimen Handling & Collection Instructions
Page 1 of 6 Non-Gynecologic Cytology Specimen Handling & Collection Instructions Labelling and Requisition Requirements Specimen Container Patients full name ( printed in same format as patients health
More informationNucleic Acid Amplification Test for Tuberculosis. Heidi Behm, RN, MPH Acting TB Controller HIV/STD/TB Program Oregon, Department of Health Services
Nucleic Acid Amplification Test for Tuberculosis Heidi Behm, RN, MPH Acting TB Controller HIV/STD/TB Program Oregon, Department of Health Services What is this test? Nucleic Acid Amplification Test (NAAT)
More informationMycobacterial Infections in HIV. H. Gene Stringer, Jr., MD Infectious Diseases Section Department of Medicine Morehouse School of Medicine
Mycobacterial Infections in HIV H. Gene Stringer, Jr., MD Infectious Diseases Section Department of Medicine Morehouse School of Medicine Learning Objectives List the most common mycobacterial infections
More information2008/7/21. An Overview. National Taiwan University College of Medicine 西元前 年. 木乃伊 (Nesperhan, priest of Amun)
Rapid Diagnosis of Tuberculosis An Overview Po-Ren Hsueh National Taiwan University College of Medicine 埃及時代 西元前 3700-1000 年 土偶 木乃伊 (Nesperhan, priest of Amun) 1 Dixon B. Lancet Infect Dis 2007;7:444-5.
More informationTB Clinical Guidelines: Revision Highlights March 2014
TB Clinical Guidelines: Revision Highlights March 2014 AIR TRAVEL & TB CONTROL With respect to non-ambulance air travel of patients diagnosed with or suspected as having active Mycobacterium tuberculosis,
More informationPrinciples of laboratory diagnosis of M. tuberculosis. Anne-Marie Demers, MD, FRCPC 11 September 2017
Principles of laboratory diagnosis of M. tuberculosis Anne-Marie Demers, MD, FRCPC 11 September 2017 QUESTION Which statement is false? 1) A smear can only be on a concentrated specimen 2) It is normal
More informationDiagnosis of Tuberculosis by GeneXpert MTB/RIF Assay Technology: A Short Review
International Journal of Advanced Microbiology and Health Research www.ijamhr.com Volume 1; Issue 1; September 2017; Page No. 20-24 Review Article Diagnosis of Tuberculosis by GeneXpert MTB/RIF Assay Technology:
More informationDEPARTMENT OF MICROBIOLOGY
DEPARTMENT OF MICROBIOLOGY GENERAL INSRUCTIONS FOR COLLECTION OF DIFFERENT MICROBIOLOGY SAMPLES Good quality laboratory services means good quality medicine and better patient care. The Quality of a clinical
More informationDiagnosis and Management of TB Disease Lisa Armitige, MD, PhD September 27, 2011
TB Nurse Case Management Davenport, Iowa September 27 28, 2011 Diagnosis and Management of TB Disease Lisa Armitige, MD, PhD September 27, 2011 Lisa Armitige, MD, PhD has the following disclosures to make:
More informationCDC IMMIGRATION REQUIREMENTS:
CDC IMMIGRATION REQUIREMENTS: Technical Instructions for Tuberculosis Screening and Treatment Using Cultures and Directly Observed Therapy October 1, 2009 Table of Contents Preface...i Tuberculosis Screening...1
More informationENG MYCO WELL D- ONE REV. 1.UN 29/09/2016 REF. MS01283 REF. MS01321 (COMPLETE KIT)
ENG MYCO WELL D- ONE MYCO WELL D-ONE System for the presumptive identification and antimicrobial susceptibility test of urogenital mycoplasmas, Gardnerella vaginalis, Trichomonas vaginalis, Candida albicans
More informationStandard Operating Procedure
Standard Operating Procedure 1. Definitions Section: Laboratory Version No. 1.2 Initials: AD Title: 2.0 Testing Algorithm Revision Date: 01 Sep 2011 1.1 SOP: Standard Operating Procedure 1.2 CRF: Case
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Microbiology Department Crawley Hospital West Green Drive Crawley RH11 7DH United Kingdom Contact: Clare Reynolds Tel: +44 (0) 1293 600379
More informationMycobacterium fortuitum,
2009 177 Mycobacterium fortuitum 1 1) 2) 3) 1) 1) 4) 4) 5) 2) 1) 1) 2) 3) 4) 5) 21 3 16 21 7 1 Mycobacterium fortuitum 1 39 BHI 2 Ziehl Neelsen M. fortuitum MIC CPFX 0.2 mg/ml, MINO 0.78 mg/ml, CAM 100
More informationMycobacterium Tuberculosis: Assessing Your Laboratory Edition
Mycobacterium Tuberculosis: Assessing Your Laboratory 2009 Edition The following individuals contributed to the preparation of this edition of Mycobacteriology tuberculosis: Assessing Your Laboratory Phyllis
More informationManaging Complex TB Cases Diana M. Nilsen, MD, RN
Managing Complex TB Cases Diana M. Nilsen, MD, RN Director of Medical Affairs NYC Department of Health & Mental Hygiene Bureau of TB Control Case #1 You are managing a patient who was seen at a private
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest
More informationTuberculosis Procedure ICPr016. Table of Contents
Tuberculosis Procedure ICPr016 Table of Contents Tuberculosis Procedure ICPr016... 1 What is Tuberculosis?... 2 Any required definitions/explanations... 2 NHFT... 2 Tuberculosis (TB)... 3 Latent TB...
More informationNucleic Acid Amplification Testing for the Diagnosis of TB
Roche Nucleic Acid Amplification Testing for the Diagnosis of TB David Warshauer, PhD Deputy Director, Communicable Diseases Wisconsin State Laboratory of Hygiene 19 th /20 th Century Traditional Algorithm
More informationNontuberculous Mycobacterial Lung Disease
Non-TB Mycobacterial Disease Jeffrey P. Kanne, MD Nontuberculous Mycobacterial Lung Disease Jeffrey P. Kanne, M.D. Consultant Disclosures Perceptive Informatics Royalties (book author) Amirsys, Inc. Wolters
More informationWhy are We Concerned with Non-Tuberculous Mycobacteria?
Why are We Concerned with Non-Tuberculous Mycobacteria? Wisconsin State Laboratory of Hygiene Julie Tans-Kersten, MS, BS-MT (ASCP) Tuberculosis Laboratory Program Coordinator Wisconsin State Laboratory
More informationMYCOBACTERIA. Pulmonary T.B. (infect bird)
MYCOBACTERIA SPP. Reservoir Clinical Manifestation Mycobacterium tuberculosis Human Pulmonary and dissem. T.B. M. lepra Human Leprosy M. bovis Human & cattle T.B. like infection M. avium Soil, water, birds,
More informationTowards Harmonization of Mycobacteriology in TB Trials. Study 31/ACTG 5349 Key Elements of Mycobacteriology Laboratory Procedures
Study 31/ACTG 5349 Key Elements of Mycobacteriology Laboratory Procedures: Towards Harmonization of Mycobacteriology in TB Trials Title Author(s) Study 31/ACTG 5349 Key Elements of Mycobacteriology Laboratory
More informationDirectorate of Laboratory Medicine. Manchester Cytology Centre Non gynaecological cytology service User Manual January 2011
Directorate of Laboratory Medicine Manchester Cytology Centre Non gynaecological cytology service User Manual January 2011 Table of contents About us 2 Services available at the Manchester Cytology Centre
More informationA retrospective evaluation study of diagnostic accuracy of Xpert MTB/RIF assay, used for detection of Mycobacterium tuberculosis in Greece
Örebro University School of Health and Medical Science Biomedical Laboratory Science Programme 180 credits Degree project in biomedical laboratory science, advanced course, 15 credits May 21, 2015 A retrospective
More informationStandard Diagnostic Procedure for Tuberculosis: A Review
ISSN: 2249 8656 www.stmjournals.com Standard Diagnostic Procedure for Tuberculosis: A Review Suresh Jaiswal*, Jay Prakash Sah, Bhoopendra Sharma Department of Medical Lab Science, School of Health and
More informationThe most current laboratory testing information can be obtained at
About Adventist Lab Partners Reference Laboratory Adventist Lab Partners (ALPs) Reference Laboratory is affiliated with Adventist Health System. Adventist Lab Partners has been a hospital-based laboratory
More informationHealth Care Worker Training on Roll Out New TB Diagnostic Test. Prepared by: City Health (J Caldwell) & NHLS (M Bosman & I Noordien)
Health Care Worker Training on Roll Out New TB Diagnostic Test Prepared by: City Health (J Caldwell) & NHLS (M Bosman & I Noordien) Overview Specimen Collection Investigations to request Sorting & registering
More information